Association of furosemide and amiloride in patients with essential hypertension. Effect on the excretion of Na, K, Cl and on urine volume
Chávez de Los Rios, J.M.; Otero Cagide, F.; Alfaro Cano, L.; Gatica Laborde, V.
La Prensa Medica Mexicana 43(3-4): 89-94
1978
ISSN/ISBN: 0032-7468 PMID: 364462 Document Number: 135447
Document emailed within 1 workday
Related Documents
Korochkin, I.M.; Vinogradova, I.V.; Aleksandrov, A.A.; Oganov, R.G. 1973: Effect of furosemide on the excretion of catecholamines in urine Kardiologiia 13(9): 106-110Memezawa, H.; Abe, K.; Irokawa, N.; Chiba, H.; Yasujima, M. 1975: Sodium metabolism in essential hypertension. Renin subgroups and changes of urinary sodium excretion caused by furosemide Nihon Jinzo Gakkai Shi 17(2): 63-68
Fang, C.C.; Chen, Y.M.; Chu, T.S.; Hsieh, B.S. 1993: Correlation between renin responsiveness to furosemide and antihypertensive effect of captopril in patients with normal-renin essential hypertension Journal of the Formosan Medical Association 92(11): 937-941
Lindroos, M.; Lehtonen, A. 1984: Timolol and a hydrochlorothiazide-amiloride combination in the treatment of essential hypertension in young and middle-aged patients: a comparative study with once-daily administration International Journal of Clinical Pharmacology Therapy and Toxicology 22(12): 643-645
Kantelip, J.P.; Aiache, J.M.; Beyssac, E.; Abella, M.L. 1991: Comparative study of pharmacokinetics and effects on urinary secretion of electrolytes of furosemide and furosemide-amiloride in healthy subjects Therapie 46(6): 475-479
Boehncke, E.; Krutzinna, C. 1991: The relationship between the urine minute volume and mineral excretion in sow urine Deutsche Tierärztliche Wochenschrift 98(2): 45-47
Tomov, I.; Elenkova, A. 1986: Plasma volume changes in essential hypertension patients Vutreshni Bolesti 25(3): 108-112
Bolzano, K.; Krempler, F.; Sandhofer, F. 1984: A combination of methyldopa, hydrochlorothiazide and amiloride in the treatment of essential hypertension Acta Medica Austriaca 11(2): 49-53
Brown, M.J.; Causon, R.C.; Barnes, V.F.; Brennan, P.; Barnes, G.; Greenberg, G. 1985: Urinary catecholamines in essential hypertension: results of 24-hour urine catecholamine analyses from patients in the Medical Research Council trial for mild hypertension and from matched controls Quarterly Journal of Medicine 57(222): 637-651
Januszewicz, W.; Wocial, B.; Sznajderman, M.; Feltynowski, T. 1977: Adrenaline excretion and cardiovascular complications in patients with essential hypertension Polski Tygodnik Lekarski 32(9): 349-351
Salvadeo, A.; Villa, G.; Segagni, S.; Moroni, G.; Poggio, F. 1988: Validity of a fixed atenolol/hydrochlorothiazide/amiloride combination (100/25/2.5 mg) in the therapy of essential arterial hypertension Minerva Cardioangiologica 36(3): 109-113
Christensen, N.J. 1977: Increased excretion of adrenaline in the urine of patients with labile hypertension and episodic tachycardia Ugeskrift for Laeger 139(49): 2938-2940
Leth, A. 1970: Changes in plasma and extracellular volume during long-term hydrochlorthiazide treatment of patients with essential hypertension Nordisk Medicin 84(33): 1042-1046
Yang, Z.L. 1993: Twenty four-hour arterial blood pressure and urinary norepinephrine excretion rate in patients with essential hypertension Zhonghua Xin Xue Guan Bing Za Zhi 21(6): 373-5 381
Cugini, P.; Serdoz, R.; Manconi, R.; Mancini, A.; Meucci, T. 1978: Effects of furosemide on plasma renin and aldosterone in three subtypes of essential hypertension Bollettino della Societa Italiana di Biologia Sperimentale 54(2): 111-115
Mörlin, C.; Aberg, H. 1981: The effect of salt restriction and furosemide in patients investigated for renovascular hypertension Acta Chirurgica Scandinavica 147(3): 169-172
Frati, L.; Mozzi, R.; Rossi, R.; Covelli, I. 1971: Effect of amiloride (MK-870 or 3-carboguanidino-2,6-diamino-5-chloropyrazine) on urinary electrolyte excretion Il Farmaco; Edizione Pratica 26(10): 626-631
Takeda, Y.; Miyamori, I.; Ikeda, M.; Koshida, H.; Yasuhara, S.; Nagai, K.; Morise, T.; Takimoto, H.; Takeda, R. 1985: Responses of plasma bradykinin and the renin-angiotensin axis to furosemide in essential hypertension Nihon Jinzo Gakkai Shi 27(4): 525-531
Molaschi, M.; Bartoli, E.; Viara, A.; Puggioni, G. 1970: Use of the association of furosemide and reserpine in the treatment of arterial hypertension Minerva Medica 61(20): 953-960
Linquette, M.; Fossati, P.; Devarenne, M.F.; Scherpereel, P. 1970: Furosemide-reserpine association in the treatment of arterial hypertension (37 cases) Lille Medical: Journal de la Faculte de Medecine et de Pharmacie de l'Universite de Lille 15(3 Suppl. 2): 432-439